Delivery Order SPE2DB24D6041-SPE2DB25FKBLM

Award Date 11/21/24
Potential Completion Date 11/22/24
Potential Value $6.2K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The U.S. government's Defense Logistics Agency (DLA) awarded a delivery order contract worth $1,094.03 to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of 4,567,356,680 units of Albendazole 200 mg tablets. This order is part of a larger Indefinite Delivery Contract (IDC) the company holds with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The IDC provides a comprehensive range of pharmaceutical...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,043.18 firm fixed-price delivery order is for the supply of 4,566,651,274 units of Albendazole 200 mg tablets, with a completion date of December 10, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,181.29 firm fixed price delivery order is for the supply of Albendazole 200 mg tablets. The contract has a performance period ending on December 22, 2022. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, which provides a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,052.60 firm fixed-price delivery order is for the supply of 4,566,707,538 units of the medication Albendazole 200 mg tablets. The contract has an ultimate completion date of December 13, 2024 and was awarded on December 12, 2024. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC)...
This federal contract award, valued at $3,803.80, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for 4,567,844,545 tablets of Albendazole 200 mg, a medication used to treat certain parasitic infections. The contract has a firm fixed price and an ultimate completion date of April 9, 2025. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery...
This federal contract award, valued at $10,939.97, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for the supply of Albendazole 200 mg tablets, a medication used to treat certain parasitic infections. The contract is not set aside and is a firm fixed-price arrangement. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the...
This federal contract award, valued at $8,755.60, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the delivery of 4,564,409,375 units of Albendazole 200 mg tablets. The contract is a Firm Fixed Price Delivery Order with an ultimate completion date of April 29, 2024. Amerisourcebergen, a major pharmaceutical distributor, holds a large Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,314.76, is a delivery order for the supply of 4566411381 - Albendazole 200 mg Tablets. This award is a child contract under a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA, valued at $999,999,999 and running through November 2026. The...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, identified as SPE2DX15D3112 and SPE2DX25FDZFS, is a delivery order for 4,566,407,323 ALBENDAZOLE 200 MG TABLET 2S, valued at $23,849.30. The award has an ultimate completion date of November 13, 2024, and is a firm fixed-price contract. This contract is not designated as a...
This federal contract award was issued by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $76,011.20 firm fixed-price delivery order is for the supply of 4,547,936 units of Albendazole 200mg tablets. The award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which provides a comprehensive...
  • SPE2DB24D6041
    Indefinite Delivery Contract
  • SPE2DB24D6041-SPE2DB25FKBLM
    Delivery Order

This federal contract award is a delivery order worth $6,218.81 to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, issued by the Defense Logistics Agency (DLA), is for the supply of Albendazole 200 mg tablets. It is an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract also has a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at $750,000 through May 2024, covering similar medical products and prescription drugs. This contract award does not have a set-aside designation, indicating open competition.

Generated 2/20/25, 9:29 AM